Show Summary Details
Page of

Ablation of the atrio-ventricular (AV) junction 

Ablation of the atrio-ventricular (AV) junction
Chapter:
Ablation of the atrio-ventricular (AV) junction
Author(s):

Yaver Bashir

, Timothy R. Betts

, and Kim Rajappan

DOI:
10.1093/med/9780199550180.003.0156
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 September 2018

Indications for ablation 330

Pacing issues with AV junction ablation 332

Standard right-sided femoral approach 334

Left-sided or transaortic approach 340

The subclavian approach 342

Outcomes and post-procedure management 344

Common pitfalls and troubleshooting 346

In patients with atrial fibrillation where rate control is required, AV nodal blocking agents such as B-blockers, calcium channel blockers, and digoxin are used. Where medical therapy proves ineffective or causes severe adverse effects, catheter ablation of the AV junction (commonly referred to as AV node ablation) is an important and effective means of achieving ventricular rate control. However, a permanent pacemaker must be implanted because the junctional escape rhythm after ablation is typically slow and unreliable (...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.